2:45 pmHighlighting Mechanism of Action of FASN Inhibitor Denifanstat in MASH
Time: 2:45 pm
day: Combination & Sequential Therapy Focus Day
Details:
- Reviewing preclinical activity of FASN inhibitor combined with semaglutide or resmetirom
- Highlighting efficacy of denifanstat added to background GLP1 treatment in Ph2b FASCINATE-2
- Planning Phase 1 PK assessment of denifanstat and resmetirom
